Shenzhen Kekaika Technology Co.,Ltd. – Trademark Portfolio
Entity Type: 99
Shenzhen Kekaika Technology Co.,Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include NIDAGE. The owner is based in Longhua Dist.,Shenzhen.
503,Tongsheng Chuangye Bldg.
Tongsheng Comprehensive Village, Dalang
Longhua Dist.,Shenzhen 518000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Shenzhen Kekaika Technology Co.,Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Shenzhen Kekaika Technology Co.,Ltd. have?
Shenzhen Kekaika Technology Co.,Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.
What trademark classes does Shenzhen Kekaika Technology Co.,Ltd. file in?
Shenzhen Kekaika Technology Co.,Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are Shenzhen Kekaika Technology Co.,Ltd.'s most well-known trademarks?
Shenzhen Kekaika Technology Co.,Ltd.'s registered trademark portfolio includes well-known marks such as NIDAGE. These are among 1 currently registered trademark in the portfolio.
What is Shenzhen Kekaika Technology Co.,Ltd.'s trademark registration success rate?
Shenzhen Kekaika Technology Co.,Ltd. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.